Allogenic Transplant in AML: How Does ASCT Compare to Chemo in Older Patients? Is FLT3i Sorafenib the Best Option for Post-Transplant Maintenance?
By
2nd SOHO Italian Conference
FEATURING
Attilio Olivieri
By
2nd SOHO Italian Conference
FEATURING
Attilio Olivieri
Login to view comments.
Click here to Login